• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度一家重症监护病房对产碳青霉烯酶肠杆菌科细菌进行直肠筛查。

Rectal screening for carbapenemase-producing Enterobacteriaceae in an intensive care unit in India.

作者信息

Sachu Arun, Sunny Sanjo, Mathew Philip, Kumar Ajeesh, David Alice

机构信息

Department of Microbiology, Believers Church Medical College Hospital, Thiruvalla, Kerala, India.

Department of Critical Care, Believers Church Medical College, Thiruvalla, Kerala, India.

出版信息

Ghana Med J. 2024 Jun;58(2):156-164. doi: 10.4314/gmj.v58i2.7.

DOI:10.4314/gmj.v58i2.7
PMID:40927070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12416220/
Abstract

OBJECTIVES

To determine the proportion of patients admitted to ICU who are colonised with carbapenem-resistant Enterobacteriaceae (CRE) and to estimate the agreement between colonised patients and patients who developed an infection with CRE.

DESIGN

Prospective surveillance study.

SETTING

The ICU of a tertiary care hospital in Kerala, India.

PARTICIPANTS

All patients above 18 were admitted to the ICU during the study period.

OUTCOME MEASURES

Patients colonised with CRE and systemic infection with the colonised organism.

RESULTS

CRE colonisation was found in 20(8.7%) samples. Among the 20 patients in the study who were colonised with CRE, 5(25%) developed systemic infection due to CRE. History of antibiotic usage and admission to other hospitals in the last 90 days were independent predictors of CRE colonisation.

CONCLUSION

Five of the 20 patients colonised with CRE developed an infection. Hospital admission and antibiotic usage were the main risk factors associated with CRE colonisation. Antibiotic escalation was suggested for two colonised patients based on their clinical worsening, but they succumbed to the illness. This study led us to modify our infection control practices, which led to isolating patients colonised with CRE.

FUNDING

None declared.

摘要

目的

确定入住重症监护病房(ICU)且被耐碳青霉烯类肠杆菌科细菌(CRE)定植的患者比例,并评估定植患者与发生CRE感染患者之间的一致性。

设计

前瞻性监测研究。

地点

印度喀拉拉邦一家三级护理医院的ICU。

参与者

研究期间所有18岁以上入住ICU的患者。

观察指标

被CRE定植的患者以及定植菌引起的全身感染。

结果

在20份(8.7%)样本中发现了CRE定植。在研究中被CRE定植的20名患者中,有5名(25%)因CRE发生了全身感染。抗生素使用史和过去90天内入住其他医院是CRE定植的独立预测因素。

结论

20名被CRE定植的患者中有5名发生了感染。住院和抗生素使用是与CRE定植相关的主要危险因素。根据两名定植患者的临床病情恶化情况,建议升级抗生素治疗,但他们最终因病死亡。这项研究促使我们修改了感染控制措施,对被CRE定植的患者进行隔离。

资金来源

未声明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d95/12416220/36031066c9cd/GMJ5802-0156Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d95/12416220/36031066c9cd/GMJ5802-0156Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d95/12416220/36031066c9cd/GMJ5802-0156Fig1.jpg

相似文献

1
Rectal screening for carbapenemase-producing Enterobacteriaceae in an intensive care unit in India.印度一家重症监护病房对产碳青霉烯酶肠杆菌科细菌进行直肠筛查。
Ghana Med J. 2024 Jun;58(2):156-164. doi: 10.4314/gmj.v58i2.7.
2
Carbapenem-Resistant Enterobacterales in Indian ICU Patients: Molecular Insights, Risk Factors, and Clinical Impact.印度重症监护病房患者中耐碳青霉烯类肠杆菌科细菌:分子见解、危险因素及临床影响
Microb Drug Resist. 2025 Sep;31(9):279-286. doi: 10.1177/10766294251366395. Epub 2025 Aug 11.
3
An update on carbapenem-resistant Enterobacterales: A prospective study from Western India.耐碳青霉烯类肠杆菌科细菌的最新情况:来自印度西部的一项前瞻性研究。
J Postgrad Med. 2025 Apr 1;71(2):61-67. doi: 10.4103/jpgm.jpgm_558_24. Epub 2025 Jun 9.
4
Prevalence and mortality associated with multidrug-resistant infections in adult intensive care units in Argentina (PREV-AR).阿根廷成人重症监护病房多重耐药感染的患病率及死亡率(PREV-AR)。
Antimicrob Agents Chemother. 2025 Mar 5;69(3):e0142624. doi: 10.1128/aac.01426-24. Epub 2025 Jan 22.
5
Improved diagnostic stewardship in carbapenem-resistant gene detection helps in early initiation of targeted therapy.改善耐碳青霉烯类基因检测中的诊断管理有助于早期启动靶向治疗。
J Med Microbiol. 2025 Jun;74(6). doi: 10.1099/jmm.0.002029.
6
Carbapenem-resistant Enterobacterales among patients with bloodstream infections in South Africa: Consolidated surveillance data, 2015-2021.南非血流感染患者中耐碳青霉烯类肠杆菌科细菌:2015 - 2021年综合监测数据
PLoS One. 2025 Jul 2;20(7):e0324262. doi: 10.1371/journal.pone.0324262. eCollection 2025.
7
Analysis of clinical characteristics of patients with coronavirus disease 2019 based on a superior carbapenem-resistant Enterobacterales identification strategy.基于一种高级耐碳青霉烯类肠杆菌鉴定策略的2019冠状病毒病患者临床特征分析
Medicine (Baltimore). 2025 Jun 27;104(26):e43046. doi: 10.1097/MD.0000000000043046.
8
Phenotypic characterisation and prevalence of carbapenem-resistant Enterobacterales in a tertiary care centre in Bihar India.印度比哈尔邦一家三级医疗中心耐碳青霉烯类肠杆菌科细菌的表型特征及流行情况
Sci Rep. 2025 Aug 26;15(1):31477. doi: 10.1038/s41598-025-04460-z.
9
Rapid screening for carbapenemase-producing carbapenem-resistant : clinical implementation of an immunochromatographic test using broth-enriched rectal swabs.产碳青霉烯酶的耐碳青霉烯菌的快速筛查:使用肉汤增菌直肠拭子进行免疫层析试验的临床应用
Microbiol Spectr. 2025 Sep 2;13(9):e0131325. doi: 10.1128/spectrum.01313-25. Epub 2025 Aug 8.
10
Multispecies emergence of dual carbapenemase-producing Enterobacterales recovered from invasive infections in Chile.从智利侵袭性感染中分离出的产双碳青霉烯酶肠杆菌科细菌的多物种出现情况。
Antimicrob Agents Chemother. 2025 Jan 31;69(1):e0120524. doi: 10.1128/aac.01205-24. Epub 2024 Dec 5.

本文引用的文献

1
The importance of active surveillance of carbapenem-resistant Enterobacterales (CRE) in colonization rates in critically ill patients.重要的是对危重症患者定植率进行碳青霉烯类耐药肠杆菌科(CRE)的主动监测。
PLoS One. 2022 Jan 20;17(1):e0262554. doi: 10.1371/journal.pone.0262554. eCollection 2022.
2
Admission screening and cohort care decrease carbapenem resistant enterobacteriaceae in Vietnamese pediatric ICU's.入院筛查和队列护理可降低越南儿科 ICU 中的碳青霉烯类耐药肠杆菌科。
Antimicrob Resist Infect Control. 2021 Aug 30;10(1):128. doi: 10.1186/s13756-021-00994-9.
3
Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions - New Jersey, February-July 2020.
2020年2月至7月新泽西州一家急症医院在新冠病毒疾病住院人数激增期间医院获得性耐碳青霉烯鲍曼不动杆菌感染和定植增加情况
MMWR Morb Mortal Wkly Rep. 2020 Dec 4;69(48):1827-1831. doi: 10.15585/mmwr.mm6948e1.
4
Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department.在急诊住院后,重症监护病房中耐碳青霉烯类肠杆菌科定植的风险增加。
Emerg Infect Dis. 2020 Jun;26(6):1156-1163. doi: 10.3201/eid2606.190965. Epub 2020 Jun 17.
5
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections.碳青霉烯类耐药革兰氏阴性菌感染的治疗选择。
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S565-S575. doi: 10.1093/cid/ciz830.
6
Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections.高流行地区碳青霉烯类耐药肠杆菌科细菌定植筛查:意大利 CRE 感染工作组立场文件。
Antimicrob Resist Infect Control. 2019 Aug 13;8:136. doi: 10.1186/s13756-019-0591-6. eCollection 2019.
7
Impact of individualized active surveillance of carbapenem-resistant enterobacteriaceae on the infection rate in intensive care units: a 3-year retrospective study in a teaching hospital of People's Republic of China.耐碳青霉烯类肠杆菌科细菌个体化主动监测对重症监护病房感染率的影响:一项在中国某教学医院开展的为期3年的回顾性研究
Infect Drug Resist. 2019 May 24;12:1407-1414. doi: 10.2147/IDR.S201644. eCollection 2019.
8
Active Surveillance of Carbapenemase-Producing Organisms (CPO) Colonization With Xpert Carba-R Assay Plus Positive Patient Isolation Proves to Be Effective in CPO Containment.Xpert Carba-R 检测联合阳性患者隔离在产碳青霉烯酶菌定植的主动监测中可有效控制产碳青霉烯酶菌。
Front Cell Infect Microbiol. 2019 May 14;9:162. doi: 10.3389/fcimb.2019.00162. eCollection 2019.
9
WHO Global Priority Pathogens List: A Bibliometric Analysis of Medline-PubMed for Knowledge Mobilization to Infection Prevention and Control Practices in Bahrain.世界卫生组织全球重点病原体清单:对Medline-PubMed进行文献计量分析以促进巴林感染预防与控制实践中的知识传播
Oman Med J. 2019 May;34(3):184-193. doi: 10.5001/omj.2019.37.
10
Management of carbapenem-resistant Enterobacteriaceae infections.碳青霉烯类耐药肠杆菌科感染的管理。
Clin Microbiol Infect. 2019 Aug;25(8):943-950. doi: 10.1016/j.cmi.2019.04.013. Epub 2019 Apr 18.